ORC1 in health and disease: from DNA replication to cancer

ORC1, the core subunit of the eukaryotic origin recognition complex, plays a critical role in DNA replication initiation, chromatin remodeling, and cell cycle regulation. Under physiological conditions, ORC1 maintains genomic stability by coordinating replication origin licensing, helicase loading, and nucleosome organization, whereas its dysregulation is closely associated with the development and progression of various tumors. ORC1 exhibits context-dependent essentiality in cancer, and targeted strategies such as small-molecule inhibitors are currently under investigation. However, clinical validation of ORC1-directed therapies remains pending, and the current evidence base is predominantly correlative and mechanistic rather than therapeutic. By integrating mechanistic insights with clinical perspectives, this review provides new viewpoints for precision medicine, while highlighting that key issues, including ORC1-independent replication mechanisms, require further investigation.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-10-13
DOI
https://doi.org/10.1186/s12967-026-08776-w
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ORC1 in health and disease: from DNA replication to cancer

Xueqin Guo, Rongrong Mu, Chunyan Zhao, Shuang Li
Journal of Translational Medicine
Cancer-related Molecular Pathways
article

ORC1 in health and disease: from DNA replication to cancer

Xueqin Guo, Rongrong Mu, Chunyan Zhao, Shuang Li
article en

Abstract

ORC1, the core subunit of the eukaryotic origin recognition complex, plays a critical role in DNA replication initiation, chromatin remodeling, and cell cycle regulation. Under physiological conditions, ORC1 maintains genomic stability by coordinating replication origin licensing, helicase loading, and nucleosome organization, whereas its dysregulation is closely associated with the development and progression of various tumors. ORC1 exhibits context-dependent essentiality in cancer, and targeted strategies such as small-molecule inhibitors are currently under investigation. However, clinical validation of ORC1-directed therapies remains pending, and the current evidence base is predominantly correlative and mechanistic rather than therapeutic. By integrating mechanistic insights with clinical perspectives, this review provides new viewpoints for precision medicine, while highlighting that key issues, including ORC1-independent replication mechanisms, require further investigation.

Journal of Translational Medicine
Second Military Medical University (CN), Third People's Hospital of Chengdu (CN), Fourth People's Hospital of Sichuan Province (CN), Shanghai University of Medicine and Health Sciences (CN), Gaozhou People's Hospital (CN)
Openalex Percentile: Top 18%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.